Literature DB >> 18704968

Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.

Cristina P Rodriguez1, David J Adelstein, Lisa A Rybicki, Jerrold P Saxton, Robert R Lorenz, Benjamin G Wood, Marshall Strome, Ramon M Esclamado, Pierre Lavertu, Marjorie A Carroll.   

Abstract

BACKGROUND: Determining which patients benefit from larynx preservation strategies remains problematic. We reviewed our experience using multiagent concurrent chemoradiotherapy to identify clinical predictors for success.
METHODS: Cisplatin and fluorouracil were given during weeks 1 and 4 of radiation to 115 patients with locoregionally advanced larynx or hypopharynx squamous cell cancer without cartilage invasion or laryngeal destruction. Laryngectomy was reserved for local failure.
RESULTS: The 5-year Kaplan-Meier projected overall survival was 58%, survival with larynx preservation 52%, local control without surgery 82%, local control (including surgical salvage) 94%, and survival with functional larynx 49%. Local control without surgery was superior in patients with T1-2 versus T3-4 tumors (97% vs 77%, p = .032). No other clinical parameters proved predictive of local control.
CONCLUSION: Larynx preservation was successful in all subsets of appropriately selected patients. Although local failure was more likely in patients with T3-4 tumors, it was infrequent and surgical salvage was effective. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704968     DOI: 10.1002/hed.20902

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

Review 1.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

2.  Clinical Predictors of Laryngeal Preservation Rate in Stage III-IV Laryngeal Cancer and Hypopharyngeal Cancer Patients Treated with Organ Preservation.

Authors:  Kanograt Tangsriwong; Tastsanachart Jitreetat
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

3.  Laryngeal preservation in stage III/IV resectable laryngo-hypopharyngeal squamous cell carcinoma following concurrent chemoradiotherapy with capecitabine/cisplatin.

Authors:  Dongbin Ahn; Jae Hyug Kim; Jin Ho Sohn; Chang-Min Sin; Jeong Eun Lee
Journal:  Mol Clin Oncol       Date:  2013-05-09

4.  Onset of hypothyroidism after total laryngectomy: Effects of thyroid gland surgery and preoperative and postoperative radiotherapy.

Authors:  Robert E Plaat; Boukje A C van Dijk; Anneke C Muller Kobold; Roel J H M Steenbakkers; Thera P Links; Bernard F A M van der Laan; Boudewijn E C Plaat
Journal:  Head Neck       Date:  2019-12-13       Impact factor: 3.147

5.  Effectiveness of ultrasonography and computed tomography in assessing thyroid cartilage invasion in laryngeal and hypopharyngeal cancers.

Authors:  Nilu Malpani Dhoot; B Choudhury; A C Kataki; L Kakoti; S Ahmed; J Sharma
Journal:  J Ultrasound       Date:  2017-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.